Sangamo Therapeutics
SGMO
#10604
Rank
$30.65 M
Marketcap
$0.07400
Share price
0.00%
Change (1 day)
-85.49%
Change (1 year)

Sangamo Therapeutics (SGMO) - Net assets

Net assets on the balance sheet as of March 2026 : -$18.96 Million USD

According to Sangamo Therapeutics 's latest financial reports the company has -$18.96 Million USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sangamo Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$82.88 M-71.9%
2022-12-31$$0.29 B-21.42%
2021-12-31$$0.37 B-24.53%
2020-12-31$$0.49 B14.93%
2019-12-31$$0.43 B17.83%
2018-12-31$$0.36 B95.45%
2017-12-31$$0.18 B37.96%
2016-12-31$$0.13 B-29.23%
2015-12-31$$0.19 B-6.87%
2014-12-31$$0.20 B69.77%
2013-12-31$$0.12 B87.55%
2012-12-31$$64.89 M-19.01%
2011-12-31$$80.13 M43.33%
2010-12-31$$55.9 M-22.12%
2009-12-31$$71.78 M29.58%
2008-12-31$$55.39 M-23.19%
2007-12-31$$72.12 M48.08%
2006-12-31$$48.7 M28.8%
2005-12-31$$37.81 M16.79%
2004-12-31$$32.37 M-27.5%
2003-12-31$$44.66 M-17.67%
2002-12-31$$54.24 M-34.13%
2001-12-31$$82.34 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
$81.52 B-430,218.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$11.68 B-61,761.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$18.84 B-99,535.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
$17.63 B-93,120.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$11.74 B-62,057.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$41.98 B-221,593.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$3.60 B-19,112.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$6.32 B-33,451.04%๐Ÿ‡บ๐Ÿ‡ธ USA